Aspen Pharmacare Holdings Stock Return On Equity
Aspen Pharmacare Holdings fundamentals help investors to digest information that contributes to Aspen Pharmacare's financial success or failures. It also enables traders to predict the movement of Aspen Pink Sheet. The fundamental analysis module provides a way to measure Aspen Pharmacare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aspen Pharmacare pink sheet.
Aspen |
Aspen Pharmacare Holdings Company Return On Equity Analysis
Aspen Pharmacare's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Aspen Pharmacare Return On Equity | 0.095 |
Most of Aspen Pharmacare's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspen Pharmacare Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Aspen Pharmacare Holdings has a Return On Equity of 0.095. This is 100.4% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 130.65% lower than that of the firm.
Aspen Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aspen Pharmacare's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Aspen Pharmacare could also be used in its relative valuation, which is a method of valuing Aspen Pharmacare by comparing valuation metrics of similar companies.Aspen Pharmacare is currently under evaluation in return on equity category among its peers.
Aspen Fundamentals
Return On Equity | 0.095 | |||
Return On Asset | 0.0499 | |||
Profit Margin | 0.17 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 4.58 B | |||
Shares Outstanding | 444.95 M | |||
Shares Owned By Insiders | 19.32 % | |||
Shares Owned By Institutions | 60.77 % | |||
Price To Earning | 11.83 X | |||
Price To Book | 0.98 X | |||
Price To Sales | 0.10 X | |||
Revenue | 38.61 B | |||
Gross Profit | 18.29 B | |||
EBITDA | 10.61 B | |||
Net Income | 6.49 B | |||
Cash And Equivalents | 7.88 B | |||
Cash Per Share | 17.25 X | |||
Total Debt | 105 M | |||
Debt To Equity | 0.38 % | |||
Current Ratio | 1.96 X | |||
Book Value Per Share | 159.44 X | |||
Cash Flow From Operations | 5.37 B | |||
Earnings Per Share | 0.80 X | |||
Number Of Employees | 8.58 K | |||
Beta | 0.62 | |||
Market Capitalization | 3.92 B | |||
Total Asset | 111.38 B | |||
Retained Earnings | 28.4 B | |||
Working Capital | 16.1 B | |||
Current Asset | 37.2 B | |||
Current Liabilities | 21.1 B | |||
Z Score | 22.2 | |||
Annual Yield | 0.02 % | |||
Net Asset | 111.38 B | |||
Last Dividend Paid | 3.26 |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Aspen Pink Sheet
If you are still planning to invest in Aspen Pharmacare Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aspen Pharmacare's history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |